Literature DB >> 21045105

Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results.

Kristine Yaffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045105     DOI: 10.1001/jama.2010.1625

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 2.  Resveratrol as a therapeutic agent for Alzheimer's disease.

Authors:  Teng Ma; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-11-26       Impact factor: 3.411

3.  Echinacoside Suppresses Amyloidogenesis and Modulates F-actin Remodeling by Targeting the ER Stress Sensor PERK in a Mouse Model of Alzheimer's Disease.

Authors:  Yuan Dai; Guanghui Han; Shijun Xu; Yongna Yuan; Chunyan Zhao; Tao Ma
Journal:  Front Cell Dev Biol       Date:  2020-11-19

Review 4.  Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.

Authors:  Md Habibur Rahman; Rokeya Akter; Tanima Bhattacharya; Mohamed M Abdel-Daim; Saad Alkahtani; Mohammed W Arafah; Norah S Al-Johani; Norah M Alhoshani; Nora Alkeraishan; Alhanof Alhenaky; Omar H Abd-Elkader; Hesham R El-Seedi; Deepak Kaushik; Vineet Mittal
Journal:  Front Pharmacol       Date:  2020-12-30       Impact factor: 5.810

5.  GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect of Xanthoceras sorbifolia Extract on Alzheimer's Disease in Mice.

Authors:  Rui Han; Min Wang; Li Wang; Yichen Zhang; Xin Li; Yijun Hou; Jing Yan; Xiaojing Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-17       Impact factor: 2.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.